GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Spago Nanomedical AB (OSTO:SPAGO) » Definitions » Equity-to-Asset

Spago Nanomedical AB (OSTO:SPAGO) Equity-to-Asset : 0.83 (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Spago Nanomedical AB Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Spago Nanomedical AB's Total Stockholders Equity for the quarter that ended in Mar. 2024 was kr34.27 Mil. Spago Nanomedical AB's Total Assets for the quarter that ended in Mar. 2024 was kr41.47 Mil. Therefore, Spago Nanomedical AB's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.83.

The historical rank and industry rank for Spago Nanomedical AB's Equity-to-Asset or its related term are showing as below:

OSTO:SPAGO' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.67   Med: 0.96   Max: 0.98
Current: 0.83

During the past 13 years, the highest Equity to Asset Ratio of Spago Nanomedical AB was 0.98. The lowest was 0.67. And the median was 0.96.

OSTO:SPAGO's Equity-to-Asset is ranked better than
71.58% of 1559 companies
in the Biotechnology industry
Industry Median: 0.67 vs OSTO:SPAGO: 0.83

Spago Nanomedical AB Equity-to-Asset Historical Data

The historical data trend for Spago Nanomedical AB's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spago Nanomedical AB Equity-to-Asset Chart

Spago Nanomedical AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.98 0.98 0.96 0.96 0.78

Spago Nanomedical AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.96 0.98 0.97 0.78 0.83

Competitive Comparison of Spago Nanomedical AB's Equity-to-Asset

For the Biotechnology subindustry, Spago Nanomedical AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Spago Nanomedical AB's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Spago Nanomedical AB's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Spago Nanomedical AB's Equity-to-Asset falls into.



Spago Nanomedical AB Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Spago Nanomedical AB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=41.316/52.985
=0.78

Spago Nanomedical AB's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=34.274/41.468
=0.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Spago Nanomedical AB  (OSTO:SPAGO) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Spago Nanomedical AB Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Spago Nanomedical AB's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Spago Nanomedical AB (OSTO:SPAGO) Business Description

Traded in Other Exchanges
Address
Scheelevagen 22, Lund, SWE, SE-223 63
Spago Nanomedical AB is a nanomedicine company in the field of cancer diagnosis and treatment. The company's product includes SpagoPix and Tumorad. The SpagoPix product aims to improve cancer diagnosis with magnetic resonance imaging through previous detection of tumors and metastases. The Tumorad products focuses on the development of a completely new form of radionuclide therapy for tumor selective radiation therapy of cancer. The company development projects are based on a platform of polymeric materials with varoious properties for precise diagnosis and treatment of life threatening and debilitating diseases.

Spago Nanomedical AB (OSTO:SPAGO) Headlines

No Headlines